Mutation analysis of the Smad2 gene in human colon cancers using genomic DNA and intron primers

Carcinogenesis

Volumn 19, Issue 5, 1998, Pages 803-807

  Takenoshita, Seiichi ^a   Tani, Masachika ^a,b   Mogi, Akira ^a   Nagashima, Makoto ^a,c   Nagamachi, Yukio ^a   Bennett, William P ^c   Hagiwara, Koichi ^c   Harris, Curtis C ^c   Yokota, Jun ^b  

^a GUNMA UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA PRECURSOR; PRIMER DNA; PYRIMIDINE; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; COLON CANCER; CONTROLLED STUDY; DELETION MUTANT; EXON; GENE MUTATION; GENE STRUCTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRON; MAJOR CLINICAL STUDY; MAMMAL; MICROSATELLITE INSTABILITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA SPLICING; SINGLE STRAND CONFORMATION POLYMORPHISM;

BASE SEQUENCE; COLONIC NEOPLASMS; DNA; DNA PRIMERS; DNA-BINDING PROTEINS; HUMANS; INTRONS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SMAD2 PROTEIN; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 0031843618     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.5.803     Document Type: Article

References (52)

1. Kingsley,D.M. (1994) The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev., 8, 133-146.
2. ten Dijke,P., Miyazono,K. and Heldin,C.-H. (1996) Signaling via heterooligomeric complexes of type I and type II serine/threonine kinase receptors. Curr. Opin. Cell Biol., 8, 139-145.
3. Alexandrow,M.G. and Moses,H.L. (1995) Transforming growth factor β and cell cycle regulation. Cancer Res., 55, 1452-1457.
4. Taetle,R., Payne,C., Dos Santos,B., Russell,M. and Segarini,P. (1993) Effects of transforming growth factor beta 1 on growth and apoptosis of human acute myelogenous leukemia cells. Cancer Res., 53, 3386-3393.
5. DeCoteau,J.F., Knaus,P.I., Yankelev,H., Reis,M.D., Lowsky,R., Lodish,H.F., and Kadin, M.E. (1997) Loss of functional cell surface transforming growth factor beta (TGF-beta) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA., 94, 5877-5881.
6. Markowitz,S., Wang,J., Myeroff,L., et al. (1995) Inactivation of the type II TGF-β receptor in colorectal cancer cells with microsatellite instability. Science, 268, 1336-1338.
7. Parsons,R., Myeroff,L.L., Liu,B., Willson,J.K., Markowitz,S.D., Kinzler, K.W. and Vogelstein,B. (1995) Microsatellite instability and mutations of the transforming growth factor βtype II receptor gene in colorectal cancer. Cancer Res., 55, 5548-5550.
8. Takenoshita,S., Tani,M., Nagashima,M., Hagiwara,K., Bennett,W.P., Yokota,J. and Harris,C.C. (1997) Mutation analysis of coding sequence of the entire transforming growth factor beta type II receptor gene in sporadic human colon cancer using genomic DNA and intron primers. Oncogene, 14, 1255-1258.
9. Takenoshita,S., Hagiwara,K., Gemma,A., Nagashima,M., Ryberg,D., Lindstedt,B.A., Bennett,W.P., Haugen,A. and Harris,C.C. (1997) Absence of mutations in the transforming growth factor-β type II receptor in sporadic lung cancers with microsatellite instability and rare H-ras 1 alleles. Carcinogenesis, 18, 1427-1429.
10. Tani,M.,Takenoshita,S., Kohno,T., Hagiwara,K., Nagamachi,Y., Harris,C.C. and Yokota,J. (1997) Infrequent mutations of the transforming growth factor beta-type II receptor gene at chromosome 3p22 in human lung cancers with chromosome 3p deletions. Carcinogenesis, 18, 1119-1121.
11. Massagué,J. (1996) TGFβ signaling: receptors, trunsducers and MAD proteins. Cell, 85, 947-950.
12. Derynck,R. and Zhang,Y. (1996) Intracellular signaling: the Mad way to do it. Curr. Biol., 6 1226-1229.
13. Sekelsky,J.J, Newfeld,S.J., Raftery,L.A., Chartoff,E.H. and Gelbart,W.M. (1995) Genetic characterization and cloning of Mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster, Genetics, 139, 1347-1358.
14. Savage,C., Das,P., Finelli,A.L., Townsend,S.R. Sun,C.-Y., Baird,S.E. and Padgett,R.W. (1996) The C elegans sma-2, sma-3 and sma-4 genes define a novel conserved family of TGF-β pathway components. Proc. Natl Acad. Sci. USA., 93, 790-794.
15. Graff,J.M., Bansal,A. and Melton,D.A. (1996) Xenopus Mad proteins transduce distinct subsets of signals for the TGFβ superfamily. Cell, 85, 479-487.
16. Baker,J.C. and Harland,R.M. (1996) A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway. Genes Dev., 10, 1880-1889.
17. Yingling,J.M., Das,P., Savage,C., Zhang,M., Padgett,R.W. and Wang,X.-F. (1996) Mammalian Dwarfins are phosphorylated in response to TGF-β and are implicated in control of cell growth. Proc. Natl Acad. Sci. USA., 93, 8940-8944.
18. Chen,Y., Lebrun,J.-J. and Vale,W. (1996) Regulation of transforming growth factor β- and activin-induced transcription by mammalian Mad proteins. Proc. Natl Acad. Sci. USA., 93, 12992-12997.
19. Riggins,G.J., Thiagalingam,S., Rozenblum,E., Weinstein,C.L., Kern,S.E., Hamilton,S.R., Willson,J.K.V., Markowitz,S.D., Kinzler,K.W. and Vogelstein,B. (1996) Mad-related genes in the human. Nature Genet., 13, 347-349.
20. Derynck,R., Gelbart,W.M., Harland,R.M., et al.,(1996) Nomenclature: vertebrate mediators of TGFβ family signals. Cell, 87, 173.
21. Hoodless,P.A., Haerry,T., Abdollah,S., Stapleton,M., O'Connor,M.B., Attisano,L. and Wrana,J.L. (1996) MADR1, a MAD-related protein that functions in BMP2 signaling pathway. Cell, 85, 489-500.
22. Liu,F., Hata,A., Baker,J.C., Doody,J., Carcamo,J., Harland,R.M. and Massagué,J. (1996) A human Mad protein acting as a BMP-regulated transcriptional activator. Nature, 381, 620-623.
23. Zhang,Y., Feng,X.-H., Wu,R.-Y. and Derynck,R. (1996) Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature, 383, 168-172.
24. Lagna,G., Hata,A., Hemmati-Brivanlou,A. and Massagué,J. (1996) Partnership between DPC4 and SMAD proteins in TGF-β signaling pathway. Nature, 383, 832-836.
25. Chen,X., Rubock,M.J. and Whitman,M. (1996) A transcriptional partner for MAD proteins in TGF-β signaling. Nature, 383, 691-696.
26. Macias-Silva,M., Abdollah,S., Hoodless,P.A., Pirone,R., Attisano,L. and Wrana,J.L. (1996) MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signalling. Cell, 87, 1215-1224.
27. Riggins,G.J., Kinzler,K.W., Vogelstein,B. and Thiagalingam,S. (1997) Frequency of Smad gene mutations in human cancers. Cancer Res., 57, 2578-2580.
28. Eppert,K., Scherer,S.W., Ozcelik,H., et al. (1996) MADR2 maps to 18q21 and encodes a TGFβ MAD-related protein that is functionally mutated in colorectal carcinoma. Cell, 86, 543-552.
29. Topper,J.N., Cai,J., Qiu,Y., et al. (1997) Vascular MADs: Two novel MAD-relaled genes selectively inducible by flow in human vascular endothelium. Proc. Natl Acad. Sci. USA., 94, 9314-9319.
30. Hayashi,H., Abdollah,S., Qiu,Y., et al.(1997) The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling. Cell, 89 1165-1173.
31. Hahn,S.A., Schutte,M., Shamsul Hoque,A.T.M., et al. (1996) DPC4, candidate tumor suppressor gene at human chromosome 18q21.1. Science, 271, 350-353.
32. Schutte,M., Hruban,R.H., Hedrick,L., et al. (1996) DPC4 gene in various tumor types. Cancer Res., 56, 2527-2530.
33. Nagatake,M., Takagi,Y., Osada,H., Uchida,K., Mitsudomi,T., Saji,S., Shimokata,K. and Takahashi,T. (1996) Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res., 56, 2718-2720.
34. Thiagalingam,S., Lengauer,C., Leach,F.S., et al. (1996) Evalution of candidate tumor suppressor genes on chromosome 18 in colorectal cancers. Nature Genet., 13, 343-346.
35. Uchida,K., Nagatake,M., Osada,H., Yatabe,Y., Kondo,M., Mitsudomi,T., Masuda,A. and Takahashi,T. (1996) Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers. Cancer Res., 56, 5583-5585.
36. Harris,C.C. (1996) Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J. Natl Cancer Inst., 88, 1442-1455.
37. Okamoto,A., Demetrick,D.J., Spillare,E.A., et al. (1994) Overexpression of human cyclin D1 reduces the transforming growth factor beta (TGF-beta) type II receptor and growth inhibition by TGF-beta 1 in an immortalized human esophageal epithelial cell line. Proc. Natl Acad. Sci. USA, 91, 11045-11049.
38. Takenoshita,S., Mogi,A., Nagashima,M., Yang,K., Yagi,.K. Hanyu,A., Nagamachi,Y., Miyazono,K. and Hagiwara,K. (1998) Characterization of the MADH2/Smad2 gene, a human Mad homolog responsible for the transforming growth factor-β and activin signal transduction pathway. Genomics (in press).
39. Ishimaru,G., Adachi,J., Shiseki,M., Yamaguchi,N., Muto,T. and Yokota,J. (1995) Microsatellite instability in primary and metastatic colorectal cancers. Int. J. Cancer, 64, 153-157.
40. Liu,B., Nicolaides,N.C., Markowitz,S., et al. (1995) Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nature Genet., 9, 48-55.
41. Hagiwara,K. and Harris,C.C. (1996) 'Long distance sequencer' method; a novel strategy or large DNA sequencing project. Nucleic Acids Res., 24, 2460-2461.
42. Takenoshita,S., Hagiwara,K., Nagashima,M., Gemma,A., Bennett,W.P. and Harris,C.C. (1996) The genomic structure of the gene encoding the human transforming growth factor β type II receptor (TGF-β RII). Genomics, 36, 341-344.
43. Fu,X.-Y., Ge,H. and Manley,J.L. (1988) The role of the polypyrimidine stretch at the SV40 early pre-mRNA 3′ splice site in alternative splicing. EMBO J., 7, 809-817.
44. Roscigno,R.F., Weiner,M. and Garcia-Blanco,M.A. (1993) A mutational analysis of the polypyrimidine tract of introns. J. Biol. Chein., 268, 11222-11229.
45. Norton,P.A. (1994) Polypyrimidine tract sequence direct selection of alternative branch sites and influence protein binding. Nucleic Acids Res., 22, 3854-3860.
46. Wrana,J.L. and Attisano,L. (1996) MAD-related proteins in TGFβ signaling. Trends Genet., 12, 493-496.
47. Weiringa,B., Hofer,E. and Weissmann,C. (1984) A minimal intron length but no specific internal sequence is required for splicing the large rabbit β-globin intron. Cell, 37, 915-925.
48. Ruskin,B. and Green,M.R. (1985) Role of 3′ splice site consensus sequence in mammalian pre-mRNA splicing. Nature, 317, 732-734.
49. Chu,C.-S., Trapnell,B.C., Curristin,S., Cutting,G.R. and Crystal,R.G. (1993) Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nature Genet., 3, 151-156.
50. Mauillon,J.L., Michel,P., Limacher,J.-M., et al. (1996) Identification of novel germline hMLH1 mutation including a 22 kb Alu-mediated deletion in patient with familial colorectal cancer. Cancer Res., 56, 5728-5733.
51. Xu,C.-F., Chambers,J.A., Nicolai,H., et al.(1997) Mutation and alternative splicing of the BRCA1 gene in UK breast/ovarian cancer families. Genes, Chrom. Cancer, 18, 102-110.
52. Malkhosyan,S., Rampino,N., Yamamoto,H. and Perucho,M. (1996) Frameshift mutator mutations. Nature, 382, 499-500.